Business Context and Reporting Period
Company: Smith & Nephew plc (LSE: SN, NYSE: SNN)
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Filing Date: February 6, 2025
Reporting Period: This filing serves as a timing announcement for the full year results ended December 31, 2024. The actual financial results are scheduled for release on February 25, 2025.
Key Financial Metrics
This filing is a preliminary announcement and does not contain specific financial results for the 2024 period. The filing text does not provide a clear value for 2024 revenue, profit, cash flow, margins, debt, or liquidity.
Historical Context (2023): The company generated annual sales of $5.5 billion in 2023.
Material Changes
No material changes to financial performance are reported in this document as the 2024 results have not yet been released.
Guidance, Outlook, and Risks
Upcoming Events:
- Results Announcement: Tuesday, February 25, 2025, at 7:00 am GMT / 2:00 am EDT.
- Conference Call: Immediately following the announcement at 8:30 am GMT / 3:30 am EDT.
Forward-Looking Statements and Risks: The filing includes standard disclaimers regarding forward-looking statements. Key risk factors identified include:
- Geopolitical conflicts in Europe and the Middle East.
- Economic conditions affecting healthcare providers and payers.
- Regulatory approvals, reimbursement decisions, and government actions.
- Product defects, recalls, or quality management failures.
- Supply chain disruptions and cybersecurity threats.
- Foreign exchange volatility.
- Integration risks related to acquisitions and disposals.
Investor Verification Checklist
- Verify the release of the full year 2024 financial results on February 25, 2025.
- Confirm the details of the conference call via the company's investor relations website.
- Review the upcoming Form 20-F for detailed risk factors and historical financial data.
- Monitor for any updates regarding the $5.5 billion 2023 sales baseline in the context of 2024 performance.